An observational study in Metabolism, Trauma and Nutritional Deficiency, sponsored by Romanian Society for Enteral and Parenteral Nutrition. Recruiting at 1 site in Romania. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-22.
Sponsored by Romanian Society for Enteral and Parenteral Nutrition · Observational
This prospective observational randomized study aims to determine energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with very high protein content and enteral nutrition formulas with normal protein content.
ImpACt of very high protein Content enteral nUtrition formulas on protein metabolism and residual gastric volume in critically ill MUltipLe trAuma paTiEnts
Background and rationale:
Despite an increased survival among critically ill patients, many of the ICU "survivors" may develop prolonged functional disabilities. It has already been proven that nutritional therapy is essential, considering that an adequate provision of calories and proteins may influence patients prognostic.
Multiple trauma patients are on a particular nutritional risk, since their high nitrogen demands and associated nutritional therapy challenges, caused by repeated surgical intervention or multiple imagistic procedures. Although nutritional therapy impact on mortality is still in debate, clear, positive results were obtained in decreasing ICU and hospital stay after adequate nutritional support.
According to ESPEN guideline on clinical nutrition in the ICU early enteral nutrition (within 48 h) should be initiated in order to assure an adequate calorie and protein intake. Beside optimal timing, the management of nutrition therapy in critically ill patients should also integrate the optimal route and caloric/protein targets.
Energy requirements monitoring through indirect calorimetry has been proposed as a standard-of-care method for critically ill patients, considering its proven superiority towards predictive equation.
Beyond calorie intake, proteins proved to play a central role in maintain lean body mass, healing wounds and supporting immune function.For multiple trauma patients it was reported that protein losses may reach 14 % of the total body stores, thus this type of patients are exposed to a particular increased risk of protein deficits. If calorie administration benefits from a proper monitoring tool, protein requirements are still based on predictive equation. The impact of protein administration is also lacking of direct measurements techniques. Lean body mass evaluation by ultrasound and computerized tomography has been reported to have a good correlation with hospital stay and pots-ICU functional capacity. Moreover muscle function evaluation through a hand-grip dynamometer was also tested with good results in patients with ARDS.
Source of administered protein may also influence nitrogen balance, considering that whey proteins (rich in leucine) promote a slower hydrolysis and allow a longer period for absorption.
Reaching the recommended goals is often impeded by gastric intolerance manifested through increased gastric volume residues. It has been already demonstrated that large gastric volume residues are associated with impaired absorption and an increased incidence of aspiration pneumonia.
Gastrointestinal dysfunction in multiple trauma patients admitted to the intensive care unit (ICU) is an important yet underrecognized consequence. There are various causes of gastrointestinal tract dysfunction mostly related to patients general health condition and to their diagnostics. Gastrointestinal failure may be induced by several factors like immunological, biological and mechanical barrier disruption and it may be manifested through stress ulceration, bacterial translocation, ileus, intra-abdominal hypertension, diarrhoea and constipation.
Whether residual gastric volume monitoring should be regularly performed has been extensively discussed. Although the results from some randomised trials which focused on monitoring gastric residual volume, did not find any difference in outcomes, this measurement was far for being abandoned. Moreover, gastric residual volume monitoring is still an essential component of enteral nutrition patient care.
Although several monitoring methods for gastric volume residue measurements were described, there is no generally accepted technique for daily use.
Objective:
This prospective observational randomized study aims to determine energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with very high protein content and enteral nutrition formulas with normal protein content.
Safety points:
Study population Consecutive patients with multiple trauma intubated and mechanical ventilated, admitted to the intensive care unit (ICU).
Sample size calculation Since the hypotheses of the study are exploratory, no formal sample size calculation has been performed. This prospective observational study aims to recruit>70 multiple trauma patients.
Randomization:
Simple randomization method will be used to assign subjects into two groups A and B.
Ethical considerations:
This study will be conducted in full conformity with the Declaration of Helsinki and Good Clinical Practices.
Local ethical committee approval will be asked before any patient will be included.
Considering that nutritional support has become a standard-of-care in every intensive care unit in the world, it is considered that this research is based on collecting data routinely available for every critically ill patient. Although no intervention is performed an informed consent will be provided.
Taking into account that the included patients are not able to provide informed consent at the time of recruitment (on ICU admission), a Power of Attorney or a Legal tutor will act as Consultee and will be asked to consent/decline participation to the study on legal behalf of the patient. If patients have Advance Decision Plan including participation in research studies the Plan will be respected and recruitment pursued/abandoned accordingly.
After regaining capacity, all patients will be asked to provide Informed Consent for using their personal data and will be given the possibility to:
Provide Informed Consent for the acute data and follow-up. Deny research participation and request destruction of acute data collected.
Study participant research data, which is for purposes of statistical analysis and scientific reporting, will be transmitted to the Data Manager and the Statistician of the study.
Expected impact of the study KNOWLEDGE The investigators aim to provide a detailed description of protein administration using two different types of enteral formulas. The main objectives of the study are to evaluate energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with different protein content. Nevertheless, the investigators want to provide data about the impact of these different enteral nutrition formulas on body composition as well as on functionality.
Regarding of the obtained data a change on local and national recommendation considering enteral nutrition in multiple trauma patients is to be expected.
Funding All the enteral nutrition products are donated by the Nutricia Global. No funding will be received for this study.
139 studies on the registry are indexed under Multiple Trauma; 32 are open to participants now.
This study's planned enrollment of 70 is below the median of 200 across 84 observational studies indexed under Multiple Trauma.
Browse Multiple Trauma studies →Romanian Society for Enteral and Parenteral Nutrition is the lead sponsor of 3 studies on the registry; 3 are open to participants now.
Compared within Multiple Trauma, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Wounds and Injuries. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Consecutive patients with multiple trauma intubated and mechanical ventilated, admitted to the intensive care unit (ICU)
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Group A - enteral formula with 6.3 g/100 ml protein
Other: Medical food
enteral formula with 10 g/100 ml protein
Other: Medical food
enteral formulas with different protein composition
Calorie and protein target
Differences regarding achieving protein and calorie daily targets in grams per kilogram of body weight (g/kg BW) at day 5 of the intervention period and at day 10 when using enteral nutrition formulas with different protein content
Time frame: on day 5 days
Calorie and protein target
Differences regarding achieving protein and calorie daily targets in grams per kilogram of body weight (g/kg BW) at day 5 of the intervention period and at day 10 when using enteral nutrition formulas with different protein content
Time frame: on day 10
Ultrasound-guided assessment of gastric residual volume
Differences regarding residual gastric volume when using enteral nutrition formulas with different protein content. Ultrasound assessment of gastric volume using a current model for GV assessment based on antral cross-sectional area (CSA) - GV (ml)1⁄427.0+14.6×right-lateral CSA (cm2)21.28×age (yr)
Time frame: on day 5
Ultrasound-guided assessment of gastric residual volume
Differences regarding residual gastric volume when using enteral nutrition formulas with different protein content. Ultrasound assessment of gastric volume using a current model for GV assessment based on antral cross-sectional area (CSA) - GV (ml)1⁄427.0+14.6×right-lateral CSA (cm2)21.28×age (yr)
Time frame: on day 10
Muscle function
Muscle function evaluation using handgrip dynamometer after extubation and sedation cessation
Time frame: 24 hours after extubation
Muscle function
Muscle function evaluation using handgrip dynamometer after extubation and sedation cessation
Time frame: 5 days after extubation
Body composition - Fat-free body mass
Fat-free body mass assessment using bioelectrical impedance analysis
Time frame: 24 hours after extubation
Body composition - Fat-free body mass
Fat-free body mass assessment using whole-body bioelectrical impedance
Time frame: 5 days after extubation
Body composition - Total body water
Total body water assessment using whole-body bioelectrical impedance analysis
Time frame: 24 hours after extubation
Body composition - Total body water
Total body water assessment using whole-body bioelectrical impedance analysis
Time frame: 5 days after extubation
Body composition - Phase angle
Phase angle measurement using whole-body bioelectrical impedance analysis
Time frame: 24 hours after extubation
Body composition - Phase angle
Phase angle measurement using whole-body bioelectrical impedance analysis
Time frame: 5 days after extubation
Body composition - ultrasound
Quadriceps rectus femoris thickness thickness measured by B-mode ultrasonography
Time frame: baseline (on admission/first 24 hours)
Body composition - ultrasound
Quadriceps rectus femoris thickness measured by B-mode ultrasonography
Time frame: on day 5
Body composition - ultrasound
Quadriceps rectus femoris thickness measured by B-mode ultrasonography
Time frame: on day 10
Body composition - ultrasound
Quadriceps rectus femoris thickness measured by B-mode ultrasonography
Time frame: on day 15
Inflammation - CRP
Plasmatic levels of C-reactive protein
Time frame: on day 5
Inflammation - CRP
Plasmatic levels of C-reactive protein
Time frame: on day 10
Inflammation - prealbumin
Plasmatic levels of prealbumin
Time frame: on day 5
Inflammation - prealbumin
Plasmatic levels of prealbumin
Time frame: on day 10
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — Data requests can be submitted by researchers in the field of clinical nutrition starting 9 months after article publication and the data will be made accessible for up to 3 years. Extensions will be considered on a case-by-case basis
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report
Time frame: 2024 3 years
Access criteria: Interest in data analysis, appropriate background in the field
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Romanian Society for Enteral and Parenteral Nutrition